Response heterogeneity of EGFR and HER2 exon 20 insertions to covalent EGFR and HER2 inhibitors

Insertion mutations in EGFR and HER2 both occur at analogous positions in exon 20. Non-small cell lung cancer (NSCLC) patients with tumors harboring these mutations seldom achieve clinical responses to dacomitinib and afatinib, two covalent quinazoline-based inhibitors of EGFR or HER2, respectively....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Res
Main Authors: Kosaka, Takayuki, Tanizaki, Junko, Paranal, Raymond M., Endoh, Hideki, Lydon, Christine, Capelletti, Marzia, Repellin, Claire E., Choi, Jihyun, Ogino, Atsuko, Calles, Antonio, Ercan, Dalia, Redig, Amanda J., Bahcall, Magda, Oxnard, Geoffrey R., Eck, Michael J., Jänne, Pasi A.
Format: Artigo
Sprog:Inglês
Udgivet: 2017
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5596996/
https://ncbi.nlm.nih.gov/pubmed/28363995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-3404
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker